Oncolytics Biotech Inc. (ONC.TO)
| Previous close | 1.5000 |
| Open | 1.5400 |
| Bid | 1.5200 x 0 |
| Ask | 1.5300 x 0 |
| Day's range | 1.5000 - 1.5400 |
| 52-week range | 1.2000 - 4.4900 |
| Volume | |
| Avg. volume | 83,537 |
| Market cap | 115.392M |
| Beta (5Y monthly) | 1.46 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript March 9, 2024 Oncolytics Biotech Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome to Oncolytics Biotech’s Fourth Quarter and Full Year 2023 Conference Call. All participants […]
- Simply Wall St.
Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
- Insider Monkey
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2023 Earnings Call Transcript
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2023 Earnings Call Transcript November 3, 2023 Oncolytics Biotech Inc. misses on earnings expectations. Reported EPS is $-0.1 EPS, expectations were $-0.07. Operator: Good morning, and welcome to Oncolytics Biotech’s Third Quarter 2023 Conference Call. All participants are now in listen-only mode. There will be a question-and-answer session at the […]
